SCYNEXIS INC (Nasdaq:SCYX)

Health Care/Life Sciences • Pharmaceuticals

CIK 1178253

Company

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

Address
1 Evertrust Plaza
13th floor
Jersey City, New Jersey 07302-6548

Employees
29

Stock Info

Close
$0.9923

Day Range
0.9300 - 1.0000

52 Week Range
0.9006 - 3.0700

Average volume
223.08K

Short Interest
841.34K (02/14/25)

% of Float Shorted
2.32%

Market Cap
$37.66M

Revenue
$140.14M

Net Income
$67.04M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$0.9124

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Guy MacDonald

President, Chief Executive Officer & Director
David Angulo Gonzalez

Independent Director
Armando Anido

Independent Director
David C. Hastings

Independent Director
Brian Philippe Tinmouth

Independent Director
Steven C. Gilman

Independent Director
Ann F. Hanham

SEC filings

Date	Form	Event
18 Dec, 2024	144
18 Dec, 2024	144
18 Dec, 2024	144
11 Dec, 2024	144
11 Dec, 2024	144
11 Dec, 2024	144
14 Nov, 2024	SC 13G/A
6 Nov, 2024	SC 13G/A
6 Nov, 2024	8-K
6 Nov, 2024	424B5
6 Nov, 2024	10-Q
7 Oct, 2024	SC 13G/A
16 Sep, 2024	4
10 Sep, 2024	8-K
27 Aug, 2024	144
27 Aug, 2024	144
27 Aug, 2024	144
22 Aug, 2024	144
22 Aug, 2024	144
22 Aug, 2024	144
8 Aug, 2024	10-Q
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
20 Jun, 2024	8-K
20 Jun, 2024	S-8
8 May, 2024	10-Q
25 Apr, 2024	ARS
25 Apr, 2024	DEF 14A
25 Apr, 2024	DEFA14A
28 Mar, 2024	8-K
28 Mar, 2024	S-8
28 Mar, 2024	10-K
16 Feb, 2024	4
13 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
9 Feb, 2024	144
5 Feb, 2024	144
30 Jan, 2024	4
30 Jan, 2024	4
30 Jan, 2024	4
18 Jan, 2024	SC 13G/A
5 Jan, 2024	8-K
2 Jan, 2024	8-K
29 Nov, 2023	SC 13G/A
28 Nov, 2023	424B5
28 Nov, 2023	424B5
27 Nov, 2023	EFFECT
27 Nov, 2023	EFFECT
21 Nov, 2023	CORRESP
21 Nov, 2023	CORRESP
21 Nov, 2023	UPLOAD
21 Nov, 2023	UPLOAD
13 Nov, 2023	S-3
13 Nov, 2023	10-Q
13 Nov, 2023	S-3
2 Oct, 2023	8-K
25 Sep, 2023	8-K
22 Sep, 2023	144
22 Sep, 2023	144
14 Aug, 2023	10-Q
18 Jul, 2023	S-8
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	8-K
23 Jun, 2023	4
23 Jun, 2023	4
16 Jun, 2023	8-K
9 Jun, 2023	SC 13G
17 May, 2023	4
10 May, 2023	10-Q
1 May, 2023	DEF 14A
1 May, 2023	ARS
1 May, 2023	DEFA14A
19 Apr, 2023	PRE 14A
13 Apr, 2023	SC 13G
3 Apr, 2023	SC 13G/A
31 Mar, 2023	S-8
31 Mar, 2023	10-K
30 Mar, 2023	8-K
15 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
1 Feb, 2023	SC 13G/A
31 Jan, 2023	4
3 Jan, 2023	4
10 Nov, 2022	S-8
9 Nov, 2022	8-K
9 Nov, 2022	10-Q
26 Oct, 2022	3
26 Oct, 2022	4
20 Oct, 2022	8-K	CEO Change
30 Sep, 2022	8-K
19 Aug, 2022	DEF 14A
15 Aug, 2022	10-Q
15 Aug, 2022	8-K
8 Aug, 2022	PRE 14A
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
17 Jun, 2022	8-K
12 May, 2022	8-K
12 May, 2022	10-Q
12 May, 2022	DEF 14A
2 May, 2022	10-K/A
2 May, 2022	PRE 14A
28 Apr, 2022	4
28 Apr, 2022	4
22 Apr, 2022	FWP
22 Apr, 2022	424B5
22 Apr, 2022	8-K
21 Apr, 2022	424B5
30 Mar, 2022	S-8
29 Mar, 2022	10-K
29 Mar, 2022	8-K
10 Mar, 2022	8-K
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
8 Feb, 2022	8-K
8 Feb, 2022	4
8 Feb, 2022	4
8 Feb, 2022	4
8 Feb, 2022	4
10 Dec, 2021	SC 13G/A
2 Dec, 2021	3
12 Nov, 2021	SC 13G/A
10 Nov, 2021	8-K
10 Nov, 2021	10-Q
4 Nov, 2021	8-K
29 Oct, 2021	8-K
17 Sep, 2021	424B3
17 Sep, 2021	424B3
15 Sep, 2021	EFFECT
13 Sep, 2021	CORRESP
10 Sep, 2021	UPLOAD
3 Sep, 2021	S-3
16 Aug, 2021	10-Q
24 Jun, 2021	8-K
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
16 Jun, 2021	8-K
10 Jun, 2021	SC 13G
18 May, 2021	8-K
17 May, 2021	424B5
17 May, 2021	10-Q
14 May, 2021	8-K
12 May, 2021	4
12 May, 2021	3
10 May, 2021	S-8
26 Apr, 2021	DEFA14A
26 Apr, 2021	DEF 14A
31 Mar, 2021	4/A
31 Mar, 2021	4/A
31 Mar, 2021	4/A
31 Mar, 2021	4/A
31 Mar, 2021	4/A
31 Mar, 2021	4/A
29 Mar, 2021	S-8
29 Mar, 2021	10-K
10 Mar, 2021	SC 13G/A
23 Feb, 2021	8-K
17 Feb, 2021	8-K
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
11 Feb, 2021	SC 13G/A
2 Feb, 2021	4
2 Feb, 2021	4
2 Feb, 2021	4
2 Feb, 2021	4
27 Jan, 2021	SC 13G
26 Jan, 2021	3
26 Jan, 2021	4
8 Jan, 2021	EFFECT
6 Jan, 2021	UPLOAD
6 Jan, 2021	CORRESP

Last update:2025-03-06 12:40:57.761418

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.